New Gene Therapy for Retinitis Pigmentosa Shows Promise
American Academy of Ophthalmology (AAO)New research suggests that a new kind of gene therapy can improve vision in people who have lost nearly all sight to retinitis pigmentosa.
/users/register&ret=/users/register&ret=/users/register&ret=/users/login/&ret=/articles/innovative-chemoenzymatic-approach-enhances-stevia-sweetness-through-glycosylation-of-rebaudioside-c/?ad2f=1&aid=818698&ad2f=1&aid=818698
New research suggests that a new kind of gene therapy can improve vision in people who have lost nearly all sight to retinitis pigmentosa.
While recovering from major surgery, Black patients may be less likely to receive certain multimodal analgesia options and more likely to receive oral opioids than white patients, according to research being presented at the ANESTHESIOLOGY® 2024 annual meeting.
New study shows customized eyeglasses successfully addressed children’s complex eye needs.
People who experience poor sleep in the month before surgery may be more likely to develop postoperative delirium, according to new research being presented at the ANESTHESIOLOGY® 2024 annual meeting.
A new, computerized, mental health assessment tool may allow doctors to quickly identify children experiencing anxiety or depression before surgery, suggests new research presented at the ANESTHESIOLOGY® 2024 annual meeting.
Six-year study results show laser treatment can preserve vision better than daily eye drops in glaucoma patients.
Severely injured Black, Asian and Hispanic children and adults are less likely than white patients to receive critical helicopter ambulance services, which can make the difference between life and death, according to a study presented at the ANESTHESIOLOGY® 2024 annual meeting.
Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, may help reduce patients’ risk of postoperative delirium, according to a study presented at the ANESTHESIOLOGY® 2024 annual meeting.
Research shows people who develop allergies as children with it persisting into adulthood tend to experience more eye complications.
A research team has successfully identified and produced the first recombinant mucin protein derived from the Edible-nest Swiftlet Aerodramus fuciphagus (AfMuc).